| SARS-CoV-2 B. 1.617. 2 Delta variant replication and immune evasion P Mlcochova, SA Kemp, MS Dhar, G Papa, B Meng, IATM Ferreira, R Datir, ... Nature 599 (7883), 114-119, 2021 | 1434 | 2021 |
| SARS-CoV-2 evolution during treatment of chronic infection SA Kemp, DA Collier, RP Datir, IATM Ferreira, S Gayed, A Jahun, ... Nature 592 (7853), 277-282, 2021 | 1045 | 2021 |
| Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity B Meng, A Abdullahi, IATM Ferreira, N Goonawardane, A Saito, I Kimura, ... Nature 603 (7902), 706-714, 2022 | 989 | 2022 |
| Sensitivity of SARS-CoV-2 B. 1.1. 7 to mRNA vaccine-elicited antibodies DA Collier, A De Marco, IATM Ferreira, B Meng, RP Datir, AC Walls, ... Nature 593 (7857), 136-141, 2021 | 752 | 2021 |
| Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2 DA Collier, IATM Ferreira, P Kotagiri, RP Datir, EY Lim, E Touizer, B Meng, ... Nature 596 (7872), 417-422, 2021 | 707 | 2021 |
| Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B. 1.1. 7 B Meng, SA Kemp, G Papa, R Datir, IATM Ferreira, S Marelli, WT Harvey, ... Cell reports 35 (13), 2021 | 477 | 2021 |
| Neutralising antibodies in Spike mediated SARS-CoV-2 adaptation SA Kemp, DA Collier, R Datir, IATM Ferreira, S Gayed, A Jahun, ... MedRxiv, 2020 | 183 | 2020 |
| SARS-CoV-2 B. 1.617 mutations L452R and E484Q are not synergistic for antibody evasion IATM Ferreira, SA Kemp, R Datir, A Saito, B Meng, P Rakshit, ... The Journal of infectious diseases 224 (6), 989-994, 2021 | 161 | 2021 |
| SARS-CoV-2 Omicron spike mediated immune escape and tropism shift B Meng, IATM Ferreira, A Abdullahi, N Goonawardane, A Saito, I Kimura, ... BioRxiv, 2021.12. 17.473248, 2021 | 107 | 2021 |
| SARS-CoV-2 B. 1.617 emergence and sensitivity to vaccine-elicited antibodies I Ferreira, R Datir, G Papa, S Kemp, B Meng, P Rakshit, S Singh, ... BioRxiv, 2021 | 98 | 2021 |
| Indian SARS-CoV-2 Genomics Consortium (INSACOG); Genotype to Phenotype Japan (G2P-Japan) Consortium; CITIID-NIHR BioResource COVID-19 Collaboration. SARS-CoV-2 B. 1.617. 2 … P Mlcochova, SA Kemp, MS Dhar, G Papa, B Meng, I Ferreira, R Datir, ... Nature 599 (7883), 114-119, 2021 | 93 | 2021 |
| SARS-CoV-2 B. 1.1. 7 sensitivity to mRNA vaccine-elicited, convalescent and monoclonal antibodies DA Collier, A De Marco, IATM Ferreira, B Meng, R Datir, AC Walls, J Bassi, ... Nature 593 (7857), 136, 2021 | 80 | 2021 |
| SARS-CoV-2 B. 1.1. 7 escape from mRNA vaccine-elicited neutralizing antibodies R Gupta, D Collier, A De Marco, I Ferreira, B Meng, R Datir, A Walls, ... | 44 | 2021 |
| Impact of SARS-CoV-2 B. 1.1. 7 Spike variant on neutralisation potency of sera from individuals vaccinated with Pfizer vaccine BNT162b2 D Collier, A De Marco, I Ferreira, B Meng, R Datir, AC Walls, J Bassi, ... | 39 | 2021 |
| SARS-CoV-2 B. 1.617. 2 Delta variant emergence, replication and sensitivity to neutralising antibodies P Mlcochova, S Kemp, MS Dhar, G Papa, B Meng, S Mishra, C Whittaker, ... BioRxiv, 2021.05. 08.443253, 2021 | 37 | 2021 |
| Age-related heterogeneity in neutralising antibody responses to SARS-CoV-2 following BNT162b2 vaccination DA Collier, IATM Ferreira, R Datir, B Meng, L Bergamaschi, ... MedRxiv, 2021.02. 03.21251054, 2021 | 34 | 2021 |
| COVID-19 Genomics UK (COG-UK) Consortium SARS-CoV-2 evolution during treatment of chronic infection SA Kemp, DA Collier, RP Datir, I Ferreira, S Gayed, A Jahun, M Hosmillo, ... Nature 592 (7853), 277-282, 2021 | 34 | 2021 |
| COVID-19 Genomics UK (COG-UK) Consortium Sensitivity of SARS-CoV-2 b. 1.1. 7 to mRNA vaccine-elicited antibodies DA Collier, A De Marco, I Ferreira, B Meng, RP Datir, AC Walls, SA Kemp, ... Nature 593, 136-141, 2021 | 28 | 2021 |
| SARS-COV-2 antibody responses to AZD1222 vaccination in West Africa A Abdullahi, D Oladele, M Owusu, SA Kemp, J Ayorinde, A Salako, D Fink, ... Nature communications 13 (1), 6131, 2022 | 25 | 2022 |
| Cell cycle regulation in macrophages and susceptibility to HIV-1 IATM Ferreira, JZ Porterfield, RK Gupta, P Mlcochova Viruses 12 (8), 839, 2020 | 24 | 2020 |
